ERBB2 and breast cancer: There were 51 luminal A (19.3%), 124 luminal B (47%), 43 triple-negative (16.3%), and 46 HER2-enriched (17.4%) in the 264 breast cancers (mean size: 28.6 ± 15.86 mm; range: 5–91 mm).